Gallium and Lutetium Power Experimental Kidney Cancer "See-and-Treat" Therapy

Aug 29, 2026

2 minute read.

Highlights

  • Gallium-68 enables PET imaging to locate kidney tumors expressing carbonic anhydrase IX, while lutetium-177 delivers targeted beta radiation to the same sites.
  • Two patients with metastatic clear cell renal cell carcinoma received the experimental agent; one developed grade 3 radiation-induced gastritis, flagging a key safety concern.
  • Tumor PET uptake reached an extraordinary SUVmax of 330, but the trial remains proof-of-concept with no confirmed clinical efficacy data yet.
  • Nuclear medicine creates a high-value downstream market where isotope purity, reactor capacity, and elemental feedstocks matter more than raw mine output.
  • Lutetium and gallium are emerging as enabling critical minerals across biotechnology, diagnostics, and precision medicine—a market dimension investors often overlook.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Spread the word:

Search

Recent REEx News

Global X Warns of $550 Billion Critical Mineral Investment Need as AI Data Centers Strain Copper and Rare Earth Supply

VanEck Flags $60 Billion Rare Earth Investment Need, but Mine-to-Magnet Deals Face a 2027 Reality Check

Viridis Mining and Minerals Awards Proxa Water Recycling Contract for Colossus Rare Earth Project in Brazil

China Rare Earth Index Hits 259.6 as Dysprosium and Terbium Rise, While Western Buyers Scramble for Yttrium

China Rare Earth Industry Association Schedules December Catalysis Summit to Advance Green Technology and Industrial Innovation

By Daniel

Inspired to launch Rare Earth Exchanges in part due to his lifelong passion for geology and mineralogy, and patriotism, to ensure America and free market economies develop their own rare earth and critical mineral supply chains.

0 Comments

No replies yet

Loading new replies...

D
DOC

Moderator

6,324 messages 106 likes

Gallium-68 and lutetium-177 pair as a 'see-and-treat' kidney cancer theranostic, showing striking tumor uptake in early human trials but serious gastric (read full article...)

Reply Like

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.